🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07019714
Starting soon Not applicable

Daoyin Technique for Improving Exercise Endurance in IPF

NCT07019714 · tracked via the Priya Life Science China tracker
Sponsor
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Phase
Not applicable
Started
2025-06-30
Last updated
2025-06-13

Condition(s) studied

Idiopathic Pulmonary Fibrosis

Investigational drug(s) / intervention(s)

Daoyin TechniqueRoutine Comprehensive Training

Daoyin Technique: On the basis of treatment guided by "Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline ", the experimental group was given Daoyin Technique for treatment. For patients who are able to complete the respiratory guidance technique. For patients who are unable to complete the respiratory guidance technique but have stable vital signs (referring to the "Expert Consensus on Respiratory Critical Care Rehabilitation Treatment Techniques in China"), the supine guidance technique is selected. It is carried out 5 days a week, 2 times a day, and each training session lasts for 30 minutes.

Routine Comprehensive Training: On the basis of treatment guided by I"Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline",the experimental group was given Routine Comprehensive Training. According to the patient's condition, select aerobic training (such as walking) or upper - limb and lower - limb resistance training (such as lifting, chest - expanding, foot - pedaling movements, etc.) combined with respiratory training (such as pursed - lip breathing, abdominal breathing, etc.). The heart rate should reach the target heart rate range and last for more than 10 minutes. This training is carried out 5 days a week, 2 times a day.

Study summary

This study is based on the previously constructed digital rehabilitation management platform, scientifically evaluating the clinical efficacy of guided technology in improving IPF exercise endurance, and forming high-quality clinical evidence.

Eligibility

Sex
ALL
Min age
40 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: 1. Patients who meet the diagnostic criteria for IPF; 2. Those who can tolerate guided - technique training; 3. Aged between 40 and 85 years old; 4. Those who can independently or with the assistance of family members use devices such as smartphones and computers during home - based training; 5. Those who voluntarily accept treatment and sign the informed consent form. Exclusion Criteria: 1. Patients in the acute exacerbation phase of IPF. 2. Patients with comorbidities such as chronic obstructive pulmonary disease, lung cancer, active pulmonary tuberculosis, bronchiectasis, pulmonary embolism, and other pulmonary diseases. 3. Patients with severe cardiovascular and cerebrovascular diseases (malignant arrhythmia, unstable angina pectoris, acute myocardial infarction, cardiac function at grade 3 or above, stroke, cerebral hemorrhage, etc.). 4. Patients with severe liver diseases (such as bleeding caused by liver cirrhosis, portal hypertension, and esophagogastric varices) and severe kidney diseases (dialysis, kidney transplantation, etc.). 5. Patients with severe osteoarthropathy or osteoporosis, and those with unstable fractures. 6. Patients with progressive neuromuscular diseases. 7. Patients with unclear consciousness, dementia, and various mental illnesses. 8. Pregnant or lactating women, and patients with a recent pregnancy plan. 9. Patients who have been participating in other clinical trials within 1 month before enrollment. 10. Patients who need long - term use of ventilators and those with unstable vital signs while bedridden.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicinenese Medicine Shenyang Liaoning

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07019714 on ClinicalTrials.gov ↗ ← All trials in China